down arrow

Cardinal Health, Inc.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: US14149Y1082
USD
199.19
-0.52 (-0.26%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

198.02200.50

52 Week

114.60214.90
Valuation
Technical
Day's Volume

CASH

661.58 k

Shareholding (Mar 2025)

FII

19.38%

Held by 392 FIIs

DII

44.35%

Held by 62 DIIs

Promoter

0.02%

How big is Cardinal Health, Inc.?

22-Jun-2025

As of Jun 24, Cardinal Health, Inc. has a market capitalization of $46.45 billion, with net sales of $222.29 billion and a net profit of $1.56 billion for the latest four quarters. Shareholder's funds are reported at -$3.21 billion, while total assets amount to $45.12 billion.

As of Jun 18, Cardinal Health, Inc. has a market capitalization of 46,451.36 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 24, the company reported net sales of 222,286.00 million and a net profit of 1,559.00 million for the latest four quarters.<BR><BR>As of Jun 24, the shareholder's funds were reported at -3,213.00 million, while total assets amounted to 45,121.00 million.

Read More

What does Cardinal Health, Inc. do?

22-Jun-2025

Cardinal Health, Inc. is a healthcare services and products company with a market cap of approximately $46.45 billion, reporting net sales of $54.88 billion and a net profit of $508 million for Q1 2025. Key metrics include a P/E ratio of 27.00 and a return on equity of -55.76%.

Overview:<BR>Cardinal Health, Inc. is a healthcare services and products company operating in the Retailing industry, with a market cap in the large-cap bracket.<BR><BR>Financial Snapshot:<BR>- Net Sales: 54,878 Million (Quarterly Results - Mar 2025)<BR>- Net Profit: 508 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 46,451.36 Million (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 27.00<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -1.48<BR>- Return on Equity: -55.76%<BR>- Price to Book: -15.76<BR><BR>Contact Details:<BR>- Address: 7000 Cardinal Pl, DUBLIN OH: 43017-1091<BR>- Tel: 1 614 7573033<BR>- Website: https://www.cardinalhealth.com/

Read More

Who are in the management team of Cardinal Health, Inc.?

22-Jun-2025

As of March 2022, Cardinal Health, Inc.'s management team includes CEO Michael Kaufmann and Independent Non-Executive Chairman Gregory Kenny, along with several Independent Directors: Carrie Cox, Calvin Darden, Bruce Downey, and Sheri Edison.

As of March 2022, the management team of Cardinal Health, Inc. includes the following individuals:<BR><BR>- Mr. Gregory Kenny, who serves as the Independent Non-Executive Chairman of the Board.<BR>- Mr. Michael Kaufmann, who is the Chief Executive Officer and a Director.<BR>- Ms. Carrie Cox, who is an Independent Director.<BR>- Mr. Calvin Darden, who is also an Independent Director.<BR>- Mr. Bruce Downey, serving as an Independent Director.<BR>- Ms. Sheri Edison, who is another Independent Director.<BR><BR>In summary, as of March 2022, Cardinal Health, Inc. has a diverse management team led by Mr. Michael Kaufmann as CEO, with Mr. Gregory Kenny as the Chairman and several Independent Directors contributing to the board.

Read More

Is Cardinal Health, Inc. overvalued or undervalued?

20-Sep-2025

As of May 5, 2022, Cardinal Health, Inc. is considered risky due to its high P/E ratio of 27, negative price-to-book value of -14.78, and elevated EV to EBITDA ratio of 15.20, despite a low PEG ratio of 0.23 and a recent 34.67% return outperforming the S&P 500.

As of 5 May 2022, Cardinal Health, Inc. moved from a very attractive valuation grade to a risky one. The company appears to be overvalued, given its high P/E ratio of 27 compared to its peer average of 24.25, and a negative price-to-book value of -14.78, indicating significant concerns about its asset valuation. Additionally, the EV to EBITDA ratio stands at 15.20, which is higher than the industry norm, suggesting that the market may be pricing in excessive growth expectations.<BR><BR>In comparison to its peers, Cardinal Health's PEG ratio of 0.23 is relatively low, but this is overshadowed by the negative book value and the high EV to Capital Employed ratio of 34.11, which raises red flags about the company's financial health. Over the past year, Cardinal Health has outperformed the S&P 500 with a return of 34.67% compared to 17.14%, but the recent weekly performance shows a decline of 1.59%, contrasting with the S&P's gain of 1.05%. This mixed performance further complicates the valuation outlook for the company.

Read More

Is Cardinal Health, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Cardinal Health, Inc. shows a bullish trend with moderate strength, supported by positive signals from moving averages and OBV, despite mixed MACD and KST indicators, and has significantly outperformed the S&P 500 with a year-to-date return of 36.88%.

As of 24 October 2025, the technical trend for Cardinal Health, Inc. has changed from mildly bullish to bullish. The current stance is bullish with moderate strength, driven by bullish signals from the daily moving averages, Bollinger Bands, and On-Balance Volume (OBV) across both weekly and monthly time frames. However, the MACD and KST indicators show mixed signals, with the weekly MACD being mildly bearish and the Dow Theory indicating a mildly bullish stance on a weekly basis but mildly bearish on a monthly basis. <BR><BR>In terms of performance, Cardinal Health has outperformed the S&P 500 significantly, with a year-to-date return of 36.88% compared to the S&P 500's 15.47%, and a one-year return of 44.34% versus 16.90%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

 
2

Flat results in Jun 25

3

Risky - Negative Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 42,348 Million (Mid Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.68

stock-summary
Return on Equity

-62.80%

stock-summary
Price to Book

-15.23

Revenue and Profits:
Net Sales:
60,159 Million
(Quarterly Results - Jun 2025)
Net Profit:
243 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
33.38%
0%
33.38%
6 Months
29.29%
0%
29.29%
1 Year
59.05%
0%
59.05%
2 Years
85.36%
0%
85.36%
3 Years
146.28%
0%
146.28%
4 Years
323.63%
0%
323.63%
5 Years
249.52%
0%
249.52%

Cardinal Health, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Cardinal Health Stock Hits Day High with 15.43% Surge in Intraday Performance

Cardinal Health Stock Hits Day High with 15.43% Surge in Intraday Performance

Cardinal Health, Inc. has seen notable stock activity, with significant gains over various time frames, including a 75.96% increase over the past year. However, the company faces challenges such as a negative book value and weak long-term fundamentals, alongside a high price-to-earnings ratio.

Read More
Cardinal Health, Inc. Hits New 52-Week High of $195.15

Cardinal Health, Inc. Hits New 52-Week High of $195.15

Cardinal Health, Inc. achieved a new 52-week high of USD 195.15 on October 30, 2025, reflecting a 92.07% stock appreciation over the past year. With a market capitalization of USD 42,348 million, the company faces challenges in profitability, as indicated by its negative return on equity and price-to-book ratio.

Read More
Cardinal Health, Inc. Sees Revision in Stock Evaluation Amid Strong Market Performance

Cardinal Health, Inc. Sees Revision in Stock Evaluation Amid Strong Market Performance

Cardinal Health, Inc. has recently revised its evaluation, with its stock price rising to $163.80. Over the past year, the company has achieved a return of 46.04%, significantly outperforming the S&P 500. The stock shows a generally positive technical outlook, despite some mixed short-term signals.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.80%
EBIT Growth (5y)
7.59%
EBIT to Interest (avg)
15.03
Debt to EBITDA (avg)
1.01
Net Debt to Equity (avg)
-1.48
Sales to Capital Employed (avg)
99.04
Tax Ratio
26.04%
Dividend Payout Ratio
31.43%
Pledged Shares
0
Institutional Holding
91.15%
ROCE (avg)
89.43%
ROE (avg)
68.50%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
-14.78
EV to EBIT
20.09
EV to EBITDA
15.20
EV to Capital Employed
34.11
EV to Sales
0.22
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
169.82%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 169 Schemes (36.25%)

Foreign Institutions

Held by 392 Foreign Institutions (19.38%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.49% vs 12.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 4.29% vs 453.03% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "60,159.00",
          "val2": "59,867.00",
          "chgp": "0.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "927.00",
          "val2": "718.00",
          "chgp": "29.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "74.00",
          "val2": "13.00",
          "chgp": "469.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-262.00",
          "val2": "-123.00",
          "chgp": "-113.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "243.00",
          "val2": "233.00",
          "chgp": "4.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.90%",
          "val2": "8.90%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is -1.87% vs 10.65% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is 83.94% vs 225.57% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "222,575.00",
          "val2": "226,826.00",
          "chgp": "-1.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,263.00",
          "val2": "2,863.00",
          "chgp": "13.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "212.00",
          "val2": "67.00",
          "chgp": "216.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-187.00",
          "val2": "-933.00",
          "chgp": "79.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,569.00",
          "val2": "853.00",
          "chgp": "83.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.10%",
          "val2": "9.50%",
          "chgp": "0.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
60,159.00
59,867.00
0.49%
Operating Profit (PBDIT) excl Other Income
927.00
718.00
29.11%
Interest
74.00
13.00
469.23%
Exceptional Items
-262.00
-123.00
-113.01%
Consolidate Net Profit
243.00
233.00
4.29%
Operating Profit Margin (Excl OI)
11.90%
8.90%
0.30%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.49% vs 12.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 4.29% vs 453.03% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Jun'25stock-summary
Jun'25
Jun'24
Change(%)
Net Sales
222,575.00
226,826.00
-1.87%
Operating Profit (PBDIT) excl Other Income
3,263.00
2,863.00
13.97%
Interest
212.00
67.00
216.42%
Exceptional Items
-187.00
-933.00
79.96%
Consolidate Net Profit
1,569.00
853.00
83.94%
Operating Profit Margin (Excl OI)
11.10%
9.50%
0.16%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2025 is -1.87% vs 10.65% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2025 is 83.94% vs 225.57% in Jun 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About Cardinal Health, Inc. stock-summary
stock-summary
Cardinal Health, Inc.
Retailing
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Company Coordinates stock-summary
Company Details
7000 Cardinal Pl , DUBLIN OH : 43017-1091
stock-summary
Tel: 1 614 7573033
stock-summary
https://www.cardinalhealth.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."